Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)

SHA:688076 Revenue

Jiangsu Sinopep-Allsino Biopharmaceutical had revenue of 552.98M CNY in the quarter ending March 31, 2026, a decrease of -2.23%. This brings the company's revenue in the last twelve months to 1.93B, up 5.21% year-over-year. In the year 2025, Jiangsu Sinopep-Allsino Biopharmaceutical had annual revenue of 1.94B with 19.57% growth.

• Revenue (ttm): 1.93B
• Revenue Growth: +5.21%
• P/S Ratio: 5.31
• Revenue / Employee: 951.77K
• Employees: 2,247
• Market Cap: 10.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.94B	318.00M	19.57%
Dec 31, 2024	1.62B	591.25M	57.21%
Dec 31, 2023	1.03B	382.26M	58.69%
Dec 31, 2022	651.29M	7.42M	1.15%
Dec 31, 2021	643.87M	77.00M	13.58%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 12, 2026

Data Sources Report a data error